Phase I/II CANON study: oncolytic immunotherapy for the treatment of non-muscle invasive bladder (NMIBC) cancer using intravesical coxsackievirus A21

被引：2
|
作者：
Pandha, H. S. [1 ]
Annels, N. [1 ]
Arif, M. [1 ]
Mostafid, H. [1 ]
Sandhu, S. [2 ]
Harrington, K. [3 ]
Melcher, A. [4 ]
Mansfield, D. [3 ]
Au, G. [5 ]
Grose, M. [5 ]
Karpathy, R. [5 ]
Shafren, D. [5 ]
机构：
[1] Univ Surrey, Clin & Expt Med, Guildford, Surrey, England
[2] Kingston Hosp, Urol, Kingston, England
[3] ICR, Targeted Therapy, London, England
[4] Leeds Inst Canc & Pathol, Oncol & Clin Res, Leeds, W Yorkshire, England
[5] Viralytics Ltd, Viralyt, Sydney, NSW, Australia
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw378.9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1054PD
引用
收藏
页数：1
相关论文
共 50 条
  • [21] INTRAVESICAL GEMCITABINE AND DOCETAXOL IN HEAVILY PRE-TREATED PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Caruso, Adele
    Ravishankar, Roshan
    VanArsdalen, Keith
    Malkowicz, Stanley
    JOURNAL OF UROLOGY, 2020, 203 : E1124 - E1124
  • [22] Analysis of inflammatory response during intravesical immunotherapy with BCG for non-muscle invasive bladder cancer
    Takeda, Yuji
    Kato, Tomoyuki
    Naito, Sei
    Ito, Hiromi
    Ushijima, Masaki
    Narisawa, Takafumi
    Kanno, Hidenori
    Kurota, Yuta
    Tsuchiya, Norihiko
    Asao, Hironobu
    CANCER SCIENCE, 2021, 112 : 841 - 841
  • [23] Analysis of urinary leukocytes during intravesical immunotherapy with BCG for non-muscle invasive bladder cancer
    Takeda, Yuji
    Kato, Tomoyuki
    Kurota, Yuta
    Ito, Hiromi
    Tsuchiya, Norihiko
    Asao, Hironobu
    CANCER SCIENCE, 2018, 109 : 978 - 978
  • [24] The treatment of non-muscle-invasive bladder cancer with intravesical chemotherapy and immunotherapy
    Whelan, Peter
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (08) : 568 - 571
  • [25] INITIAL TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) IN A LARGE INTEGRATED DELIVERY SYSTEM
    Williams, Stephen
    Luong, Tiffany
    Yi, David
    Yamamoto, Ayae
    Kawatkar, Aniket
    Kim, Philip
    Loo, Ronald
    Sidell, Margo
    Danforth, Kim
    JOURNAL OF UROLOGY, 2018, 199 (04): : E948 - E948
  • [26] Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder Cancer
    Steinberg, Ryan L.
    Thomas, Lewis J.
    O'Donnell, Michael A.
    Nepple, Kenneth G.
    BLADDER CANCER, 2015, 1 (01) : 65 - 72
  • [27] A phase I/II study of EG-70 (detalimogene voraplasmid) intravesical monotherapy for patients (pts) with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS)
    Palou, J.
    Marcq, G.
    Steinberg, G.
    Toscone, C.
    Sullivan, J.
    Linback, T.
    Pruthi, R.
    Bryce, R.
    Brown, G.
    ANNALS OF ONCOLOGY, 2024, 35 : S1165 - S1165
  • [28] LOW-GRADE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC): EFFECTS OF INDUCTION INTRAVESICAL THERAPY ON RECURRENCE AND PROGRESSION
    Lexiaochuan, Wen
    Yuanyuan, Shen
    John, Msaddi
    Andrew, Bui
    Hiroko, Miyagi
    Behzad, Jazayeri
    Adnan, Fazili
    Nagashree, Rao
    Logan, Zemp
    Philippe, Spiess
    Scott, Gilbert
    Alice, Yu
    Brandon, Manley
    Michael, Poch
    Wade, Sexton
    Julio, Pow-Sang
    Roger, Li
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [29] Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy
    Kassouf, Wassim
    Kamat, Ashish M.
    Zlotta, Alexander
    Bochner, Bernard H.
    Moore, Ronald
    So, Alan
    Izawa, Jonathan
    Rendon, Ricardo A.
    Lacombe, Louis
    Aprikian, Armen G.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2010, 4 (03): : 168 - 173
  • [30] SEQUENTIAL INTRAVESICAL GEMCITABINE AND DOCETAXEL FOR THE SALVAGE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER
    Steinberg, Ryan
    Thomas, Lewis
    O'Donnell, Michael
    Nepple, Kenneth
    JOURNAL OF UROLOGY, 2015, 193 (04): : E301 - E301
12345